The purpose of the Radioactive Drug Research Committee (RDRC) is to guarantee the highest degree of both radiation and pharmacological safety to patients who take part in either research protocols or clinical trials. It is also the RDRC’s responsibility to determine the intrinsic value of the research and weigh risk versus benefit considerations before approving such studies. Federal law defines this committee, and the FDA must individually approve its members. The FDA also specifies its composition.